Bayer receives approval for Eylea ® in China (for specialized target groups only)
Eylea ® gains approval in China for the treatment of visual impairment due to neovascular (wet) age-related macular degeneration (Source: Bayer Company News)
Source: Bayer Company News - May 11, 2018 Category: Pharmaceuticals Source Type: news
Bayer announces Executive Leadership Team for new Crop Science division
Liam Condon to lead newly combined organization (Source: Bayer Company News)
Source: Bayer Company News - May 7, 2018 Category: Pharmaceuticals Source Type: news
Bayer concludes process to sell Covestro
14.2 percent interest sold for 2.2 billion euros / 6.8 percent of shares retained to repay exchangeable bond (Source: Bayer Company News)
Source: Bayer Company News - May 4, 2018 Category: Pharmaceuticals Source Type: news
Bayer initiates full separation from Covestro
Accelerated bookbuilding process started for 14.2 percent (Source: Bayer Company News)
Source: Bayer Company News - May 3, 2018 Category: Pharmaceuticals Source Type: news
Bayer: Operational business held back by currency effects & #8211; Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx& portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year at 2.896 billion euros due to currency effects– level with prior-year quarter on a currency-adjusted basis / Sales increase at Pharmaceuticals (Fx& portfolio adj.) / Consumer Health down year on year, as expected / Sales of Crop Science match strong prior-year quarter (Fx& portfolio adj.) / Animal Health raises sales (Fx& portfolio adj.) and earnings / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and ...
Source: Bayer Company News - May 3, 2018 Category: Pharmaceuticals Source Type: news
Bayer signs agreement to sell further Crop Science businesses to BASF for up to 1.7 billion euros
Package includes global vegetable seeds business, certain seed treatments and digital farming activities / Businesses generated total sales of 745 million euros in 2017 / Sale is subject to successful closing of Monsanto acquisition (Source: Bayer Company News)
Source: Bayer Company News - April 26, 2018 Category: Pharmaceuticals Source Type: news
Temasek subscribes to capital increase and acquires approximately 3.6 percent of Bayer
Investment by renowned long-term investor affirms Bayer’s strategy (Source: Bayer Company News)
Source: Bayer Company News - April 16, 2018 Category: Pharmaceuticals Source Type: news
Bayer hones its brand profile
(Source: Bayer Company News)
Source: Bayer Company News - April 4, 2018 Category: Pharmaceuticals Source Type: news
Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancer (for specialized target groups only)
(Source: Bayer Company News)
Source: Bayer Company News - March 26, 2018 Category: Pharmaceuticals Source Type: news
